NLRX1 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NLRX1 Protein</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRX1](/genes/nlrx1)</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRX1</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NWV8</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~103 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondrial outer membrane</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>NOD-like receptor family</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">28 edges</a></td>
</tr>
</table>
...
NLRX1 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NLRX1 Protein</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRX1](/genes/nlrx1)</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRX1</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NWV8</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~103 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondrial outer membrane</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>NOD-like receptor family</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">28 edges</a></td>
</tr>
</table>
NLRX1 (NOD-like Receptor Family Member X1) is a mitochondrial antiviral signaling protein that serves as a critical regulator of innate immune responses and mitochondrial function[@moore2008]. As a member of the NLR (NOD-like receptor) family, NLRX1 is uniquely localized to the mitochondria outer membrane, where it interfaces cellular metabolism with inflammatory signaling pathways that are highly relevant to neurodegenerative disease pathogenesis[@kigerl2022].
Structure
NLRX1 contains multiple functional domains that mediate its interactions with various signaling proteins:
- N-terminal pyrin domain (PYD): Facilitates protein-protein interactions with other PYD-containing proteins
- NACHT domain: ATPase domain responsible for oligomerization and activation
- LRR domain (Leucine-Rich Repeat): Involved in ligand sensing and autoinhibition
The mitochondrial localization of NLRX1 is mediated by a mitochondrial targeting sequence that anchors the protein to the outer mitochondrial membrane (OMM), positioning it to sense mitochondrial stress and communicate with the cytosolic innate immune signaling networks[@arnoult2021].
Function
Mitochondrial Antiviral Signaling
NLRX1 was originally identified as a positive regulator of RIG-I-like receptor (RLR) signaling in antiviral immune responses. Upon viral infection, NLRX1 interacts with MAVS (Mitochondrial Antiviral Signaling Protein) on the mitochondrial surface, enhancing the downstream activation of [NF-κB](/entities/nf-kb) and type I interferon signaling pathways[@moore2008].
Regulation of Oxidative Stress
NLRX1 plays a crucial role in regulating mitochondrial [reactive oxygen species](/entities/reactive-oxygen-species) (ROS) production. Through its interactions with components of the electron transport chain, NLRX1 helps maintain mitochondrial homeostasis and prevents excessive ROS generation that could damage cellular components[@yang2020].
Modulation of Inflammasome Activity
NLRX1 negatively regulates several inflammasome complexes, including NLRP3 and AIM2 inflammasomes. This regulation occurs through direct protein-protein interactions and competitive binding with upstream activators, limiting excessive inflammatory responses that could contribute to chronic neuroinflammation[@kigerl2022].
Role in Neurodegenerative Diseases
Alzheimer's Disease
In Alzheimer's disease (AD), NLRX1 has emerged as a protective factor against [amyloid-beta](/proteins/amyloid-beta) (Aβ)-induced neurotoxicity. Studies demonstrate that NLRX1 expression is upregulated in AD brain tissue, particularly in regions vulnerable to amyloid pathology[@liu2021]. The protein appears to:
- Modulate neuroinflammation: NLRX1 limits [NLRP3 inflammasome](/entities/nlrp3-inflammasome) activation in [microglia](/cell-types/microglia-neuroinflammation), reducing the chronic inflammatory milieu that drives AD progression[@kigerl2022]
- Protect mitochondrial function: By regulating mitochondrial dynamics and ROS production, NLRX1 helps maintain neuronal energy metabolism impaired in AD[@yang2020]
- Influence amyloid processing: Emerging evidence suggests NLRX1 may affect [amyloid precursor protein](/entities/app-protein) (APP) processing through mechanisms involving mitochondrial stress signaling[@liu2021]
Parkinson's Disease
NLRX1 participates in pathways highly relevant to Parkinson's disease (PD) pathogenesis:
- Mitochondrial quality control: NLRX1 helps regulate mitophagy, the process by which damaged mitochondria are selectively degraded. Impaired mitophagy is a hallmark of PD, particularly in relation to PINK1/Parkin pathway dysfunction[@pickrell2015]
- Dopaminergic neuron survival: Through its anti-inflammatory and anti-oxidative functions, NLRX1 may protect dopaminergic [neurons](/entities/neurons) from the specific vulnerabilities they exhibit in PD[@sarkar2020]
- LRRK2 interaction: Studies suggest NLRX1 may interact with LRRK2 (leucine-rich repeat kinase 2), a major PD-associated protein, though the functional significance remains under investigation[@pickrell2015]
Amyotrophic Lateral Sclerosis
In ALS, NLRX1 is implicated in:
- Motor neuron inflammation: NLRX1 deficiency in mouse models results in heightened inflammasome activation and increased motor neuron vulnerability[@kigerl2022]
- Mitochondrial dysfunction: Given the central role of mitochondrial dysfunction in ALS pathogenesis, NLRX1's mitochondrial regulatory functions are highly relevant[@cookson2022]
- Glial cell activation: NLRX1 modulates the inflammatory phenotype of [astrocytes](/entities/astrocytes) and microglia, influencing the non-cell-autonomous toxicity that characterizes ALS[@kigerl2022]
Therapeutic Targeting
NLRX1 represents a potential therapeutic target for neurodegenerative diseases due to its central position at the intersection of mitochondrial function and innate immunity. Strategies under investigation include:
- Small molecule activators: Compounds that enhance NLRX1 function could bolster mitochondrial resilience and limit harmful inflammation
- Gene therapy approaches: Upregulating NLRX1 expression in neurons and glia may provide neuroprotective effects
- Protein-protein interaction inhibitors: Modulating NLRX1's interactions with specific partners (e.g., NLRP3, MAVS) could fine-tune its therapeutic effects
Research Directions
Key open questions in NLRX1 research include:
- Determining the precise molecular triggers that activate or inhibit NLRX1 function
- Understanding cell-type-specific roles of NLRX1 in the brain
- Developing brain-penetrant small molecules that can modulate NLRX1 activity
- Elucidating the interaction network between NLRX1 and other neurodegeneration-associated proteins
See Also
- [NLRX1 Gene](/genes/nlrx1)
External Links
- [GeneCards: NLRX1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NLRX1)
References
[Moore CB, et al, NLRX1 is a regulator of mitochondrial antiviral immunity (2008)](https://pubmed.ncbi.nlm.nih.gov/18288110/)
[Kigerl KA, et al, NLRX1 regulates inflammatory and homeostatic glial cell responses in the CNS (2022)](https://pubmed.ncbi.nlm.nih.gov/36352458/)
[Arnoult D, et al, A mitochondrial pathway of innate immune signaling (2021)](https://pubmed.ncbi.nlm.nih.gov/33911216/)
[Yang L, et al, NLRX1 attenuates oxidative stress and mitochondrial dysfunction in Parkinson's disease models (2020)](https://pubmed.ncbi.nlm.nih.gov/32535062/)
[Liu Y, et al, NLRX1 upregulation in Alzheimer's disease brain correlates with disease pathology (2021)](https://pubmed.ncbi.nlm.nih.gov/34538279/)
[Pickrell AM, Youle RJ, The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25611506/)
[Sarkar S, et al, Mitochondrial dysfunction in Parkinson's disease: Molecular insights into therapeutic potential (2020)](https://pubmed.ncbi.nlm.nih.gov/32057962/)
[Cookson MR, Mitochondrial dysfunction in Parkinson's disease: Cause or consequence? Nat Rev Neurosci (2022)](https://pubmed.ncbi.nlm.nih.gov/35428263/)